Biotech Jason Mast and Megan Molteni STAT Plus: New gene therapy, to be priced at $4.25 million, has already transformed children’s lives
Biotech Matthew Herper and Jason Mast STAT Plus: Small studies offer hope CAR-T can fight an aggressive brain cancer
Biotech Jason Mast STAT Plus: Hemophilia gene therapies arrived after 40 years of struggle. Where are the patients?
Biotech Jason Mast STAT Plus: Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff
Biotech Jason Mast STAT Plus: For unlucky mountaineers, tundra explorers, and the unhoused, a new drug could avert the ravages of frostbite
Biotech Jason Mast STAT Plus: Obscure vertigo drug could bring rare hope for patients with devastating neuron disease
Exclusive Jason Mast STAT Plus: Dewpoint Therapeutics cuts 15% of staff, acknowledges Merck, Pfizer broke off partnerships over buzzy science
Biotech Jason Mast STAT Plus: Doudna institute hatches plan to ‘cure hundreds of diseases’ left behind by CRISPR revolution
Exclusive Jason Mast STAT Plus: Feng Zhang’s year-old CRISPR delivery startup Aera lays off quarter of staff
Health Jason Mast After ‘SNL’ skit on sickle cell CRISPR therapy, advocates cite errors and stereotypes
Biotech Jason Mast and Allison DeAngelis STAT Plus: Prime Medicine, Mukherjee’s Myeloid Therapeutics clash over genome-editing deal
Biotech Jason Mast STAT Plus: After decade-long dispute over CRISPR-Cas9, Editas strikes deal with Vertex to cash in
